Table 2.
SUCRA-values for each biomarker, category and for all outcomes combined 1.
| Inflammation | Glycemic Control | Lipids and Apolipoproteins | All-Outcomes-Combined 3 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| hsCRP | IL-6 | Combined 2 | Glucose | Insulin | HOMA-IR | Combined 2 | TC | LDL-c | HDL-c | TG | ApoB | ApoA1 | Combined 2 | ||
| Mediterranean | 56.4 | 59.7 | 58.1 | 50.0 | 63.1 | 40.4 | 51.2 | 65.3 | 79.2 | 57.9 | 72.0 | 62.8 | 41.3 | 63.1 | 57.4 |
| DASH | 71.3 | 71.3 | 61.0 | 58.2 | 59.6 | 75.2 | 70.3 | 18.1 | 63.0 | 77.9 | 33.9 | 56.4 | 62.4 | ||
| Paleo | 79.0 | 95.0 | 87.0 | 35.3 | 70.7 | 89.7 | 65.2 | 32.9 | 35.5 | 78.6 | 51.1 | 49.5 | 67.2 | ||
| Dietary guidelines-based | 73.4 | 31.0 | 52.2 | 16.7 | 59.3 | 58.7 | 44.9 | 54.2 | 52.3 | 37.4 | 44.7 | 64.3 | 37.9 | 48.5 | 48.5 |
| Low GI/GL | 48.2 | 31.1 | 31.3 | 36.9 | 51.1 | 42.2 | 43.2 | 29.8 | 41.6 | ||||||
| Plant-based | 44.9 | 44.9 | 57.6 | 27.6 | 90.4 | 58.5 | 76.0 | 75.6 | 16.9 | 27.5 | 49.6 | 21.1 | 44.5 | 49.3 | |
| Low-fat | 14.5 | 20.4 | 17.5 | 48.2 | 78.5 | 35.6 | 54.1 | 74.3 | 70.7 | 28.8 | 47.6 | 77.0 | 45.1 | 57.3 | 42.9 |
| Low CHO high-fat | 31.2 | 31.2 | 80.8 | 51.9 | 66.4 | 14.8 | 16.8 | 92.6 | 91.3 | 4.3 | 93.4 | 52.2 | 49.9 | ||
| Traditional Mexican | 58.8 | 58.8 | |||||||||||||
| High GI/GL | 66.3 | 25.8 | 35.3 | 42.5 | 34.2 | 34.3 | 55.2 | 18.4 | 35.5 | ||||||
| Western habitual | 29.3 | 43.9 | 36.6 | 27.2 | 33.8 | 18.6 | 26.5 | 22.1 | 23.1 | 71.5 | 54.6 | 14.1 | 77.2 | 43.8 | 35.6 |
1 SUCRA is a value ranges from 0 to 100% that associated with each treatment in a connected network. A higher SUCRA indicates a greater chance of the associated treatment being the best for achieving a favourable outcome. 2 Category-level combined SUCRA is the average of biomarkers in the category. 3 All-outcomes-combined SUCRA is the average of category-level combined SUCRAs. Abbreviations: CHO, carbohydrate; DASH, Dietary Approaches to Stop Hypertension; GI/GL glycemic index/glycemic load; HDL-c, high-density lipoprotein cholesterol; HOMA-IR, homeostatic model assessment for insulin resistance; hsCRP, high sensitivity C-reactive protein; IL-6, interleukin-6; LDL-c, low-density lipoprotein cholesterol; SUCRA, surface under the cumulative ranking curve; TC, total cholesterol; TG, triglycerides.